Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Electrocore LLC

ECOR
Current price
7.39 USD +0.02 USD (+0.27%)
Last closed 7.25 USD
ISIN US28531P1030
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 43 516 372 USD
Yield for 12 month +16.93 %
1Y
3Y
5Y
10Y
15Y
ECOR
21.11.2021 - 28.11.2021

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey. Address: 200 Forge Way, Rockaway, NJ, United States, 07866

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

23.1 USD

P/E ratio

Dividend Yield

Current Year

+16 030 000 USD

Last Year

+8 592 000 USD

Current Quarter

+6 139 000 USD

Last Quarter

+5 443 000 USD

Current Year

+13 226 000 USD

Last Year

+6 976 000 USD

Current Quarter

+5 301 000 USD

Last Quarter

+4 555 000 USD

Key Figures ECOR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -13 467 000 USD
Operating Margin TTM -42.21 %
PE Ratio
Return On Assets TTM -49.18 %
PEG Ratio
Return On Equity TTM -153.49 %
Wall Street Target Price 23.1 USD
Revenue TTM 21 281 000 USD
Book Value 1.78 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 72.9 %
Dividend Yield
Gross Profit TTM 7 215 000 USD
Earnings per share -2.05 USD
Diluted Eps TTM -2.05 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -66.84 %

Dividend Analytics ECOR

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ECOR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:15
Payout Ratio
Last Split Date 15.02.2023
Dividend Date

Stock Valuation ECOR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.5629
Price Sales TTM 2.0448
Enterprise Value EBITDA 0.1589
Price Book MRQ 3.7933

Financials ECOR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ECOR

For 52 weeks

4.9 USD 8.08 USD
50 Day MA 6.09 USD
Shares Short Prior Month 19 073
200 Day MA 6.36 USD
Short Ratio 3.71
Shares Short 35 123
Short Percent 0.85 %